The Food and Drug Administration has approved Yeztugo, a groundbreaking HIV prevention shot by Gilead Sciences, marking what many advocates are calling a historic advance in the decades-long battle to end HIV transmission. Delivered just twice a year, Yeztugo (generic name lenacapavir) nearly eliminated new HIV infections in clinical trials, …
Read More »